Breast Fibroblasts Modulate Early Dissemination, Tumorigenesis, and Metastasis through Alteration of Extracellular Matrix Characteristics 1 2

Department of Pathology and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.
Neoplasia (New York, N.Y.) (Impact Factor: 4.25). 03/2013; 15(3):249-62. DOI: 10.1593/neo.121950
Source: PubMed


A wealth of evidence has now demonstrated that the microenvironment in which a tumorigenic cell evolves is as critical to its evolution as the genetic mutations it accrues. However, there is still relatively little known about how signals from the microenvironment contribute to the early events in the progression to malignancy. To address this question, we used a premalignant mammary model to examine how fibroblasts, and the extracellular matrix (ECM) proteins they secrete, influence progression to malignancy. Their effect on metastatic malignant cells was also assessed for comparison. We found that carcinoma-associated fibroblasts, and the distinct aligned ECM they deposit, can cause both premalignant and malignant mammary epithelial cells to assume a mesenchymal morphology that is associated with increased dissemination and metastasis, while benign reduction mammoplasty fibroblasts favor the maintenance of an epithelial morphology and constrain early dissemination, tumor growth, and metastasis. Our results suggest that normalizing the organization of the ECM could be effective in limiting systemic dissemination and tumor growth.


Available from: Bahram Parvin, May 28, 2015
  • Source
    • "This increased breast density is attributed to increased cellular and extracellular matrix components in the stroma. The cellular changes in cancer-associated stroma include changes in the number and activation of carcinoma-associated fibroblasts [59,60]. The activation of cancer-associated fibroblasts is thought to alter the environment by changing the composition of growth factors and ECM proteins and thereby plays a role in breast cancer development. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Primary cilia are microtubule-based organelles that protrude from the cell surface. Primary cilia play a critical role in development and disease through regulation of signaling pathways including the Hedgehog pathway. Recent mouse models have also linked ciliary dysfunction to cancer. However, little is known about the role of primary cilia in breast cancer development. Primary cilia expression was characterized in cancer cells as well as their surrounding stromal cells from 86 breast cancer patients by counting cilia and measuring cilia length. In addition, we examined cilia expression in normal epithelial and stromal cells from reduction mammoplasties as well as histologically normal adjacent tissue for comparison. Results We observed a statistically significant decrease in the percentage of ciliated cells on both premalignant lesions as well as in invasive cancers. This loss of cilia does not correlate with increased proliferative index (Ki67-positive cells). However, we did detect rare ciliated cancer cells present in patients with invasive breast cancer and found that these express a marker of basaloid cancers that is associated with poor prognosis (Cytokeratin 5). Interestingly, the percentage of ciliated stromal cells associated with both premalignant and invasive cancers decreased when compared to stromal cells associated with normal tissue. To understand how cilia may be lost during cancer development we analyzed the expression of genes required for ciliogenesis and/or ciliary function and compared their expression in normal versus breast cancer samples. We found that expression of ciliary genes were frequently downregulated in human breast cancers. Conclusions These data suggest that primary cilia are lost early in breast cancer development on both the cancer cells and their surrounding stromal cells.
    Cilia 07/2014; 3(1):7. DOI:10.1186/2046-2530-3-7
  • Source
    • "Metastasis has classically been considered a late event in cancer progression. However, dissemination of cells from a primary breast lesion may occur early in tumor progression, indicating that tumor progression and tumor dissemination may occur through distinct mechanisms.12,13 Remarkably, even non-metastatic or non-transformed breast cells are capable of disseminating and surviving in the lung microenvironment.13,14 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Breast cancer is a heterogeneous group of diseases that frequently exhibits loss of growth control, and disrupted tissue organization and differentiation. Several recent studies indicate that apical-basal polarity provides a tumor-suppressive function, and that disrupting polarity proteins affects many stages of breast cancer progression from initiation through metastasis. In this review we highlight some of the recent advances in our understanding of the molecular mechanisms by which loss of apical-basal polarity deregulates apoptosis, proliferation, and promotes invasion and metastasis in breast cancer.
    Breast Cancer: Targets and Therapy 01/2014; 6:15-27. DOI:10.2147/BCTT.S43764
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancers develop in complex tissue environments, which they depend on for sustained growth, invasion and metastasis. Unlike tumor cells, stromal cell types within the tumor microenvironment (TME) are genetically stable and thus represent an attractive therapeutic target with reduced risk of resistance and tumor recurrence. However, specifically disrupting the pro-tumorigenic TME is a challenging undertaking, as the TME has diverse capacities to induce both beneficial and adverse consequences for tumorigenesis. Furthermore, many studies have shown that the microenvironment is capable of normalizing tumor cells, suggesting that re-education of stromal cells, rather than targeted ablation per se, may be an effective strategy for treating cancer. Here we discuss the paradoxical roles of the TME during specific stages of cancer progression and metastasis, as well as recent therapeutic attempts to re-educate stromal cells within the TME to have anti-tumorigenic effects.
    Nature medicine 11/2013; 19(11):1423-37. DOI:10.1038/nm.3394 · 27.36 Impact Factor
Show more